HS Treatment
Options
From first-line antibiotics to cutting-edge biologics, surgical options, wound care, and lifestyle strategies. Every treatment approach for HS, explained clearly and without medical jargon.
When to Seek Urgent Care
- Rapidly spreading redness or warmth (cellulitis)
- Fever above 101°F (38.3°C) with HS symptoms
- Severe pain not controlled by current medications
- Signs of sepsis: confusion, rapid heart rate, difficulty breathing
Do not delay. Call your doctor or go to the ER.
The HS Treatment Ladder
HS treatment typically follows a stepwise approach based on disease severity. Most patients use a combination of steps simultaneously.
Topical & Oral Antibiotics
First-line for mild HS. Clindamycin topical, doxycycline or tetracycline orally. Reduces bacterial load and inflammation.
Hormonal & Retinoid Therapy
Spironolactone, oral contraceptives, and isotretinoin for patients with hormonal triggers or acne-type HS.
Biologic Therapy
Adalimumab (Humira), secukinumab (Cosentyx), and bimekizumab (Bimzelx) are FDA-approved for moderate-to-severe HS.
Surgical Intervention
Deroofing for recurrent abscesses, wide excision for advanced disease. Surgery is often combined with ongoing medical therapy.
Always work with a dermatologist to determine the right treatment plan for your individual case.
Every Treatment Resource in One Place
Nine in-depth resources covering every dimension of HS treatment, from acute flare management to long-term surgical planning.
Medical Treatments
From topical antibiotics and oral tetracyclines to biologics like adalimumab (Humira) and secukinumab (Cosentyx). Understand every medication category, how they work, and what to expect.
HS Surgery: What Patients Need to Know
A comprehensive patient guide covering incision and drainage, deroofing, wide excision, and laser surgery. Includes what to ask your surgeon, recovery timelines, and scar management.
HS Surgery Recovery
Day-by-day recovery guidance after HS surgery - wound care, activity restrictions, signs of complications, and how to support healing. Practical, patient-written advice.
How to Manage HS Flares
Evidence-based strategies for managing acute flares at home and knowing when to seek medical care. Covers warm compresses, topical treatments, pain management, and flare prevention.
HS Pain Relief
A practical guide to managing the chronic and acute pain of HS - from over-the-counter options to prescription pain management, topical treatments, and non-pharmacological strategies.
Wound Care & Hygiene
Step-by-step wound care protocols for active HS lesions, post-surgical wounds, and chronic tunnels. Includes dressing recommendations, the HS Dignity Care Kit, and hygiene routines.
HS Diet & Inflammation
Anti-inflammatory dietary strategies with evidence behind them - the low-glycemic diet, dairy elimination, the Mediterranean approach, and specific foods that may trigger or reduce flares.
Biohacking & Emerging Therapies
Explore cutting-edge and complementary approaches - low-level laser therapy, zinc supplementation, intermittent fasting, cold therapy, and the latest clinical trial results.
HS Research & Clinical Trials
Stay current with the latest published research, newly approved biologics, and active clinical trials. Find studies you may be eligible to join.
HS Treatment: Insurance Coverage & Cost Guide
Understanding what is typically covered, what costs out-of-pocket, and how to advocate for coverage is one of the most practical - and least discussed - parts of managing HS.
Typically Covered by Insurance
- Dermatologist office visits and consultations
- Oral antibiotics (doxycycline, clindamycin, rifampicin)
- FDA-approved biologics (adalimumab, secukinumab, bimekizumab) - with prior authorization
- HS surgery (incision & drainage, deroofing, wide excision) - when medically necessary
- Wound care supplies (dressings, gauze) - often covered under durable medical equipment
- Lab work and imaging ordered by your dermatologist
Typically NOT Covered (Out-of-Pocket)
- Low-level laser therapy (LLLT) for HS - not yet a standard guideline treatment
- Hyperbaric oxygen therapy (HBOT) for HS - considered experimental
- Red light therapy devices (home use)
- Dietary supplements and probiotics
- Infrared saunas and cold plunge therapy
- Cosmetic scar revision (unless functionally impairing)
- Most biohacking and emerging therapies
Biologic Medications: Prior Authorization & Cost Assistance
Biologic medications (adalimumab, secukinumab, bimekizumab) can cost $20,000–$60,000 per year at list price. Most insured patients pay far less due to prior authorization and manufacturer patient assistance programs. Key steps:
- 1Your dermatologist submits a prior authorization (PA) request to your insurer documenting medical necessity.
- 2If denied, request a peer-to-peer review between your dermatologist and the insurer's medical reviewer.
- 3If still denied, file a formal appeal. Include clinical notes, failed prior treatments, and published HS guidelines.
- 4Apply for manufacturer patient assistance: AbbVie myAbbVie Assist (Humira), Novartis Patient Assistance (Cosentyx), UCB Cares (Bimzelx).
- 5If uninsured or underinsured, explore NeedyMeds.org and RxAssist.org for prescription assistance programs and free clinic resources.
Typical Out-of-Pocket Cost Ranges
| Treatment | Insured (with PA) | Uninsured / List Price | Coverage Likelihood |
|---|---|---|---|
| Dermatologist visit | $20–$60 copay | $150–$400 | High |
| Oral antibiotics (doxycycline) | $0–$20 | $20–$80/month | High |
| Adalimumab (Humira) | $0–$150/month (with PA) | ~$6,000/month | High (with PA) |
| Secukinumab (Cosentyx) | $0–$150/month (with PA) | ~$5,000/month | High (with PA) |
| Bimekizumab (Bimzelx) | $0–$150/month (with PA) | ~$7,000/month | High (with PA) |
| HS surgery (wide excision) | $500–$3,000 (deductible/copay) | $5,000–$25,000+ | High (medically necessary) |
| LLLT (clinical sessions) | Full cost ($150–$400/session) | $150–$400/session | Low |
| HBOT for HS | Full cost ($200–$500/session) | $200–$500/session | Very Low |
Cost estimates are approximate US figures as of 2025. Actual costs depend on your specific insurance plan, deductible, and geographic location. Always verify coverage with your insurer before beginning treatment.
Biohacking & Emerging Therapies for HS
Beyond conventional medicine - explore low-level laser therapy, hyperbaric oxygen, red light therapy, cold therapy, microbiome interventions, infrared sauna, and more. A comprehensive look at cutting-edge approaches with the evidence behind each one.
Treatment FAQs
What is the most effective treatment for HS?
There is no single best treatment for all patients. For mild HS, topical and oral antibiotics are typically first-line. For moderate-to-severe HS, biologic medications such as adalimumab (Humira) have the strongest evidence base. Treatment should be individualized with a dermatologist who specializes in HS.
Can HS be treated without surgery?
Yes. Many patients manage HS effectively with medical therapy alone, including antibiotics, biologics, and hormonal treatments. Surgery is generally reserved for patients with recurrent abscesses, tunneling lesions, or extensive scarring that does not respond to medical management.
Does diet really help HS?
For some patients, dietary changes can meaningfully reduce flare frequency and severity. The most evidence-supported approaches are a low-glycemic diet and dairy elimination. Results vary significantly between individuals, and diet should complement, not replace, medical treatment.
How long does it take for biologics to work for HS?
Most patients who respond to biologic therapy see meaningful improvement within 12–16 weeks. Some patients experience faster response, while others may take up to 6 months. If there is no response after 4–6 months, switching to a different biologic is often considered.
Not Sure Where to Start?
If you are newly diagnosed or feeling overwhelmed, our step-by-step guide is designed to walk you through everything you need to know in the right order.
Medical References
- [1]Kimball AB, et al. Two phase 3 trials of adalimumab for hidradenitis suppurativa (PIONEER I and II). N Engl J Med. 2016;375(5):422-434. PubMed
- [2]Alikhan A, et al. North American clinical management guidelines for hidradenitis suppurativa. J Am Acad Dermatol. 2019;81(1):76-90. PubMed
- [3]Zouboulis CC, et al. European S1 guideline for the treatment of hidradenitis suppurativa/acne inversa. J Eur Acad Dermatol Venereol. 2015;29(4):619-644. PubMed
- [4]Jemec GBE. Hidradenitis suppurativa. N Engl J Med. 2012;366(2):158-164. PubMed
- [5]Rompel R, Petres J. Long-term results of wide surgical excision in 106 patients with hidradenitis suppurativa. Dermatol Surg. 2000;26(7):638-643. PubMed
- [6]Ingram JR, et al. Interventions for hidradenitis suppurativa: a Cochrane systematic review. Br J Dermatol. 2016;174(5):970-978. PubMed
Explore more resources